Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

Table 2

Differential expression of six miRNAs in the plasma of the PDAC and the control groups.

	PDAC (lg copies/μL)	Control (lg copies/μL)	value
miR-21			0.000
miR-210			0.013
miR-155			0.002
miR-196a			0.000
miR-20a			0.000
miR-25			0.000